Jacob Wulff

3.4k total citations
34 papers, 1.6k citations indexed

About

Jacob Wulff is a scholar working on Molecular Biology, Clinical Biochemistry and Oncology. According to data from OpenAlex, Jacob Wulff has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Clinical Biochemistry and 6 papers in Oncology. Recurrent topics in Jacob Wulff's work include Metabolomics and Mass Spectrometry Studies (16 papers), Metabolism and Genetic Disorders (8 papers) and Diet and metabolism studies (6 papers). Jacob Wulff is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (16 papers), Metabolism and Genetic Disorders (8 papers) and Diet and metabolism studies (6 papers). Jacob Wulff collaborates with scholars based in United States, United Kingdom and Australia. Jacob Wulff's co-authors include Matthew Mitchell, John Ryals, Michael V. Milburn, Luke A. D. Miller, Adam D. Kennedy, Sarah H. Elsea, Anne M. Evans, Lining Guo, Marcus J. Miller and Danny C. Alexander and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Jacob Wulff

33 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Wulff United States 21 765 268 229 226 206 34 1.6k
Sheng‐Ming Dai China 31 1.2k 1.5× 190 0.7× 364 1.6× 213 0.9× 197 1.0× 91 3.3k
Sebastian Weis Germany 26 899 1.2× 563 2.1× 312 1.4× 146 0.6× 134 0.7× 87 2.2k
Hao Ren China 30 1.3k 1.7× 416 1.6× 251 1.1× 287 1.3× 144 0.7× 107 2.6k
Marco Casciaro Italy 26 557 0.7× 415 1.5× 138 0.6× 347 1.5× 79 0.4× 80 2.6k
Simone M. R. Camargo Switzerland 29 1.0k 1.4× 95 0.4× 422 1.8× 293 1.3× 322 1.6× 54 2.5k
Asako Doi Japan 23 366 0.5× 364 1.4× 257 1.1× 212 0.9× 107 0.5× 82 1.6k
Michele Costanzo Italy 21 529 0.7× 103 0.4× 310 1.4× 138 0.6× 101 0.5× 51 1.2k
Xuefei Gao China 20 1.1k 1.5× 157 0.6× 432 1.9× 182 0.8× 41 0.2× 52 1.9k
Yingying Lü China 25 955 1.2× 503 1.9× 294 1.3× 143 0.6× 42 0.2× 65 2.1k
Mohamed El Gazzar United States 35 1.4k 1.8× 620 2.3× 195 0.9× 316 1.4× 147 0.7× 82 3.8k

Countries citing papers authored by Jacob Wulff

Since Specialization
Citations

This map shows the geographic impact of Jacob Wulff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Wulff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Wulff more than expected).

Fields of papers citing papers by Jacob Wulff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Wulff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Wulff. The network helps show where Jacob Wulff may publish in the future.

Co-authorship network of co-authors of Jacob Wulff

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Wulff. A scholar is included among the top collaborators of Jacob Wulff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Wulff. Jacob Wulff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chávez, Julio C., Michael Dickinson, Javier Muñoz, et al.. (2025). Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study. Blood. 145(20). 2303–2311. 3 indexed citations
2.
Kanters, Steve, Sara Beygi, Timothy Best, et al.. (2024). Matching-Adjusted Indirect Comparisons of Axicabtagene Ciloleucel to Mosunetuzumab for the Treatment of Relapsed/Refractory Follicular Lymphoma. Transplantation and Cellular Therapy. 30(9). 885.e1–885.e11. 2 indexed citations
3.
Ray, M. D., Steve Kanters, Sara Beygi, et al.. (2023). Matching‐adjusted indirect comparison of axicabtagene ciloleucel versus mosunetuzumab in relapsed/refractory follicular lymphoma patients after 2 prior systemic treatments. Hematological Oncology. 41(S2). 522–523. 3 indexed citations
4.
Ford, Lisa A., Matthew Mitchell, Jacob Wulff, et al.. (2022). Clinical metabolomics for inborn errors of metabolism. Advances in clinical chemistry. 107. 79–138. 7 indexed citations
5.
Kasi, Pashtoon Murtaza, Sarah Sawyer, Michelle L. Munro, et al.. (2021). BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer. BMJ Open. 11(9). e047831–e047831. 33 indexed citations
6.
Kennedy, Adam D., Lisa A. Ford, Bryan M. Wittmann, et al.. (2021). Global biochemical analysis of plasma, serum and whole blood collected using various anticoagulant additives. PLoS ONE. 16(4). e0249797–e0249797. 19 indexed citations
7.
Freed, Tiffany A., Josef Coresh, Lesley A. Inker, et al.. (2019). Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS. Clinical Chemistry. 65(3). 406–418. 17 indexed citations
8.
Wulff, Jacob & Matthew Mitchell. (2018). A Comparison of Various Normalization Methods for LC/MS Metabolomics Data. Advances in Bioscience and Biotechnology. 9(8). 339–351. 44 indexed citations
9.
Bainbridge, Matthew N., Erin Cooney, Marcus J. Miller, et al.. (2017). Analyses of SLC13A5 -epilepsy patients reveal perturbations of TCA cycle. Molecular Genetics and Metabolism. 121(4). 314–319. 47 indexed citations
10.
Kennedy, Adam D., Kirk L. Pappan, Taraka Donti, et al.. (2017). Elucidation of the complex metabolic profile of cerebrospinal fluid using an untargeted biochemical profiling assay. Molecular Genetics and Metabolism. 121(2). 83–90. 44 indexed citations
11.
Kennedy, Adam D., Marcus J. Miller, Kirk Beebe, et al.. (2016). Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of Metabolism. Genetic Testing and Molecular Biomarkers. 20(9). 485–495. 42 indexed citations
12.
Cottrell, Mackenzie L., Kuo H. Yang, Heather M. A. Prince, et al.. (2016). A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine. The Journal of Infectious Diseases. 214(1). 55–64. 218 indexed citations
13.
Fournier, Margot, Carina Ferrari, Philipp Baumann, et al.. (2014). Impaired Metabolic Reactivity to Oxidative Stress in Early Psychosis Patients. Schizophrenia Bulletin. 40(5). 973–983. 42 indexed citations
14.
Lawton, Kay A., Meredith V. Brown, Danny Alexander, et al.. (2014). Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(5-6). 362–370. 71 indexed citations
15.
Wittmann, Bryan M., Steven M. Stirdivant, Matthew Mitchell, et al.. (2014). Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine. PLoS ONE. 9(12). e115870–e115870. 100 indexed citations
16.
Clarke, Joseph D., Danny C. Alexander, John Ryals, et al.. (2013). Assessment of Genetically Modified Soybean in Relation to Natural Variation in the Soybean Seed Metabolome. Scientific Reports. 3(1). 3082–3082. 52 indexed citations
17.
Yamazaki, Makoto, Hiroko Sato, Naoya Masutomi, et al.. (2013). Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats. Toxicology and Applied Pharmacology. 268(1). 79–89. 89 indexed citations
18.
Lawton, Kay A., Merit Cudkowicz, Meredith V. Brown, et al.. (2011). Biochemical alterations associated with ALS. Amyotrophic Lateral Sclerosis. 13(1). 110–118. 76 indexed citations
19.
Parman, Toufan, Deborah I. Bunin, Jonathan E. McDunn, et al.. (2011). Toxicogenomics and Metabolomics of Pentamethylchromanol (PMCol)-Induced Hepatotoxicity. Toxicological Sciences. 124(2). 487–501. 26 indexed citations
20.
Barnes, Virginia Monsul, Ricardo Teles, Harsh M. Trivedi, et al.. (2010). Assessment of the Effects of Dentifrice on Periodontal Disease Biomarkers in Gingival Crevicular Fluid. Journal of Periodontology. 81(9). 1273–1279. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026